The Pershing Square Foundation Awards $3 Million to Innovative SARS-CoV-2 Research Projects

Business Wire (07/07/20)

The Pershing Square Foundation has awarded $3 million to nineteen recipients at 10 academic research institutions conducting research related to the SARS-CoV-2 virus. As scientists across various disciplines around the world have risen to the challenge of combatting SARS-CoV-2, the foundation worked with its network of talented cancer research scientists and physician-scientists involved in the Pershing Square Sohn Cancer Research Alliance (PSSCRA) to create a funding opportunity for SARS-CoV-2 research. The foundation's PSSCRA initiative annually awards a cancer research prize that provides funding and emboldens early-career investigators to pursue research projects at a stage when traditional funding is lacking. "The foundation remains committed to supporting cancer research and we are proud of the PSSCRA community that we have built over the last seven years," said foundation trustee Bill Ackman. "Amid this global health crisis, we felt that we had an opportunity to quickly leverage the expertise of this exceptional scientific community to identify areas in which we could rapidly deploy funds to scientists researching SARS-CoV-2 in a way similar to our approach to funding cancer research." By tapping the PSSCRA community for this project, the foundation sought to foster synergy among experts across cancer research, immunotherapy/immunology, genetics, and epigenetics to shed new light on SARS-CoV-2 research, expand basic scientific knowledge, and strengthen the arsenal for current and future health crises. Proposals were evaluated for innovation, scientific excellence, and application to the SARS-CoV-2 virus.

Read the article